stella
beta
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT — Stella
Recruiting
Back to Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
View full record on ClinicalTrials.gov